Vancouver’s Verisante Technology Inc. (TSX-V:VRS) has signed a letter of intent with a China-based strategic partner granting exclusive sales and marketing rights of its Core lung, colon, cervical and nasal cancer detection technology and its ClearVu endoscopic camera.
Read more >